L

F

LOMBARDI , Francesca

Last name: LOMBARDI

First name: Francesca

2025 (v1)

Publication

Metadata-only

Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial

Rossetti, Barbara Ferrara, Micol Taramasso, Lucia

Introduction: Central nervous system adverse events (AE) have been a cause of discontinuation of dolutegravir-containing therapy, especially in combination with abacavir. The main aim of the study was to evaluate whether the switch to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was associated with a reduction in severity and...

Uploaded on: April 17, 2025